A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adult Participants Compared to JUVÉDERM VOLUMA XC for Improvement of Mid-Face Volume
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
With several prominent research institutions and a robust healthcare network, Phoenix stands out as a significant hub for clinical trials. The city hosts leading medical centers such as the Mayo Clinic’s Scottsdale campus, the Translational Genomics Research Institute (TGen), and the Arizona State University (ASU) Biomedical Engineering department. These institutions are at the forefront of advancing clinical research and innovation. The diverse population of Phoenix provides a broad participant base too, enhancing the accuracy and relevance of clinical studies.
Why choose Phoenix for clinical trials?
Phoenix offers distinctive advantages for those volunteering in clinical trials. The city's diverse and growing population provides a rich pool of participants, which enhances the accuracy and applicability of research outcomes.
Choosing to participate in a clinical trial in Phoenix allows individuals to contribute to critical medical advancements while benefiting from a supportive and well-established clinical research environment. The city's combination of a diverse participant base and cutting-edge research facilities makes it an ideal location for advancing medical science and improving healthcare outcomes.
Common conditions studied in Phoenix
Phoenix is known for its robust clinical research landscape, addressing a wide range of medical conditions and diseases through innovative trials.
Cancer
Phoenix has become a prominent center for cancer research, leveraging institutions like the Mayo Clinic Scottsdale and the Translational Genomics Research Institute (TGen). Trials here often explore groundbreaking cancer treatments such as immunotherapy, which harnesses the body’s immune system to target cancer cells, and targeted therapies that specifically attack cancerous cells while sparing healthy ones.
Researchers in Phoenix are also investigating novel drug combinations and personalized medicine approaches to improve outcomes for patients with various cancers, including breast, prostate, and lung cancers.
Cardiovascular diseases
The city’s research efforts in cardiovascular health focus on conditions such as coronary artery disease, heart failure, and hypertension. Cardiovascular clinical trials in Phoenix evaluate new medications that aim to better manage high blood pressure and cholesterol levels, as well as innovative surgical techniques like minimally invasive valve replacements.
Studies also explore lifestyle interventions and preventive strategies such as weight management treatments to reduce the risk of cardiovascular events and improve overall heart health.
Neurological disorders
Phoenix is actively involved in researching neurological diseases, with a particular emphasis on Alzheimer's disease, Parkinson's disease, and multiple sclerosis (MS). Neurology trials often investigate potential disease-modifying drugs that could slow or halt disease progression, as well as new diagnostic tools that might improve early detection.
Research in this area also includes exploring advanced imaging techniques and cognitive therapies to enhance patient care and quality of life.
Diabetes and endocrine disorders
Clinical trials in Phoenix are at the forefront of research into diabetes and other endocrine disorders. Studies often focus on developing new insulin formulations and glucose monitoring technologies to better manage Type 1 and Type 2 diabetes. Clinical research here also explores treatments for thyroid disorders and adrenal gland diseases, aiming to improve hormone regulation and overall metabolic health.
Respiratory diseases
Phoenix's trials in respiratory diseases address chronic conditions like asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis. Research includes evaluating new inhalation devices and drug delivery systems that provide more effective symptom relief.
Trials in Phoenix also focus on innovative therapies that could potentially alter the disease course, such as biologics that target specific inflammatory pathways or novel drug combinations to manage chronic symptoms.
Autoimmune diseases
Researchers in Phoenix are engaged in trials for autoimmune conditions including rheumatoid arthritis, lupus, and multiple sclerosis (MS). These studies often investigate new immunomodulatory drugs that aim to reduce inflammation and prevent joint damage. Research also explores potential treatments that could more effectively manage symptoms and improve functional outcomes for individuals living with these chronic diseases.
Infectious diseases
Phoenix’s clinical trials also address a range of infectious diseases, such as HIV/AIDS, hepatitis, and emerging viral infections like COVID-19. Trials often focus on developing new antiviral drugs, vaccines, and treatment protocols to enhance disease management and prevention. Research in this area is crucial for addressing both ongoing and emerging infectious threats, improving patient outcomes and public health responses.
Local regulations and guidelines
In Phoenix, clinical trials are governed by both federal and state regulations to ensure safety, ethical standards, and scientific validity. At the federal level, trials must comply with guidelines established by the U.S. Food and Drug Administration (FDA). Additionally, the Office for Human Research Protections (OHRP) provides ethical standards for protecting participants’ rights and welfare.
Locally, the Arizona Board of Clinical Trials and individual institutional review boards (IRBs) within research institutions play a critical role in reviewing and approving study protocols. These bodies ensure compliance with federal regulations, including informed consent processes, participant confidentiality, and data integrity. Research sites in Phoenix must also adhere to state-specific laws and regulations, which can include additional protections for participants and requirements for reporting adverse events.
Benefits of participating in clinical trials
Participating in a clinical trial provides a distinctive opportunity to access groundbreaking treatments and therapies before they are released to the general population. Participants benefit from high-quality, personalized care delivered by top healthcare experts who ensure thorough monitoring and customized support throughout the study.
Involvement in clinical trials is crucial for advancing medical research and can lead to significant breakthroughs in the management and prevention of various conditions. By taking part, individuals not only gain early access to innovative medical interventions but also play a pivotal role in advancing scientific knowledge. This contribution helps to shape the future of healthcare, ultimately leading to better outcomes and improved treatment options for future patients.
Interested in participating in clinical trials but worried about how long they might take? Check out our comprehensive guide for all the information you need to make an informed decision.
How to enroll in a clinical trial in Phoenix
Enrolling in a clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started:
- Identify your trial: Use our intuitive search bar or filter options to locate clinical trials specific to requirements. This first step simplifies the process of finding relevant research studies tailored to your needs.
- Select your preferred location: To find trials conveniently located near you, simply input your preferred location into the dedicated filter bar on the left-hand side of the page.
- Explore study details: For in-depth information about each study, simply click the “Learn More” button. This will provide you with comprehensive details about the trial, including objectives, procedures, and eligibility criteria.
- Complete the health profile: After clicking on the “Get started” button you will be taken to our efficient 5-step application process to provide important health information. This helps us match you with the clinical trial that best fits your needs.
- Submit the application: After completing the application, send it in. A clinical trial coordinator will review it and contact you regarding the possibility of participation.